|
Vol. 12, Issue 11, 1785-1791, November 2002
METHODS
Detection of Peptides, Proteins, and Drugs That Selectively Interact With Protein Targets
Ilya G.
Serebriiskii,1
Olga
Mitina,1,2
Elena N.
Pugacheva,1
Elizaveta
Benevolenskaya,3
Elena
Kotova,1
Garabet G.
Toby,1,4
Vladimir
Khazak,5
William G.
Kaelin,3
Jonathan
Chernoff,1 and
Erica A.
Golemis1,6
1 Division of Basic Science, Fox Chase Cancer Center,
Philadelphia, Pennsylvania 19111, USA; 2 Department of
Molecular Biology and Medical Biotechnology, Russian State Medical
University, Moscow, Russia; 3 Dana-Farber Cancer Institute,
Boston, Massachusetts 02115, USA; 4 Cell and Molecular Biology
Group, University of Pennsylvania School of Medicine, Philadelphia,
Pennsylvania 19104, USA; 5 Morphochem, Inc.,
Monmouth Junction, New Jersey 08852, USA
Genome sequencing has been completed for multiple organisms, and
pilot proteomic analyses reported for yeast and higher eukaryotes. This
work has emphasized the facts that proteins are frequently engaged in
multiple interactions, and that governance of protein interaction
specificity is a primary means of regulating biological systems. In
particular, the ability to deconvolute complex protein interaction
networks to identify which interactions govern specific signaling
pathways requires the generation of biological tools that allow the
distinction of critical from noncritical interactions. We report the
application of an enhanced Dual Bait two-hybrid system to allow
detection and manipulation of highly specific protein-protein
interactions. We summarize the use of this system to detect proteins
and peptides that target well-defined specific motifs in larger protein
structures, to facilitate rapid identification of specific interactors
from a pool of putative interacting proteins obtained in a library
screen, and to score specific drug-mediated disruption of
protein-protein interaction.
[Supplemental material is available online at http://www.genome.org.
The following individuals kindly provided reagents, samples, or
unpublished information as indicated in the paper: A. Taliana, M. Russell, M. Berman, and R. Finley.]
6
Corresponding author.
12:1785-1791 ©2002 by Cold Spring Harbor Laboratory Press ISSN 1088-9051/02 $5.00

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. K. Singh, D. Dadke, E. Nicolas, I. G. Serebriiskii, S. Apostolou, A. Canutescu, B. L. Egleston, and E. A. Golemis
A Novel Cas Family Member, HEPL, Regulates FAK and Cell Spreading
Mol. Biol. Cell,
April 1, 2008;
19(4):
1627 - 1636.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. M. O'Neill, S. Seo, I. G. Serebriiskii, S. R. Lessin, and E. A. Golemis
A New Central Scaffold for Metastasis: Parsing HEF1/Cas-L/NEDD9
Cancer Res.,
October 1, 2007;
67(19):
8975 - 8979.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Yanes, J. Villanueva, E. Querol, and F. X. Aviles
Functional Screening of Serine Protease Inhibitors in the Medical Leech Hirudo medicinalis Monitored by Intensity Fading MALDI-TOF MS
Mol. Cell. Proteomics,
October 1, 2005;
4(10):
1602 - 1613.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. G. Serebriiskii, R. Fang, E. Latypova, R. Hopkins, C. Vinson, J. K. Joung, and E. A. Golemis
A Combined Yeast/Bacteria Two-hybrid System: Development and Evaluation
Mol. Cell. Proteomics,
June 1, 2005;
4(6):
819 - 826.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|